Organon jumps on report of $12 billion buyout bid

Organon & Co.

10/04/2026 12:59

Updates

** Shares of drugmaker Organon OGN.N rise 21.3% to $8.37 premarket

** India's Sun Pharmaceutical Industries SUN.NS to proceed with $12 billion binding offer for Organon, Economic Times daily reports citing sources

** Sun has completed detailed due diligence over three months and is finalizing a financing package before submitting a firm offer in the coming weeks, report says

** Sun Pharma says media reports are "speculative in nature and there is no material event or information that requires disclosure"

** OGN, focused on women's health, did not immediately respond to a Reuters request for comment outside business hours

** As of last close, OGN down 3.6% YTD

(Reporting by Sneha S K)

((Sneha.SK@thomsonreuters.com;))